Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Expand
titlets.xpt (trial summary, study level parameters)
  • Assumption: Study can have more than one assay type
  • Assumption: ASSAYID value of ALL means it applies to all assays in the study
  • Replaced the ASSAYID values of MNT with MNvit (term used in OECD #487) - is this better?  This is not a controlled term so we can use anything but what we use in our IG examples are often used in industry implementations so we should use realistic and best practice values as much as possible. 
  • BLEO & CPA - are positive controls, should this be included/where is this captured? — in results for the record / row?
  • Where is TK6 cell type?  is this test system (see below)

Row

STUDYID

ASSAYID

DOMAIN

TSSEQ

TSGRPID

TSPARMCD

TSPARM

TSVAL

TSVALNF

1123

ALL

TS1
GLPTYPGood Laboratory Practice TypeFDA
11123ALLTS1
STSTDTCStudy Start Date2007-12-30
13123ALLTS1
STITLEStudy TitleExample of a Crossover study in the Rat with 3 dose levels and 3 dosing periods
14123ALLTS1
SNDIGVERSEND Implementation Guide VersionTobacco IMPLEMENTATION GUIDE VERSION 1.0
15123

ALL

TS1
SNDCTVERSEND Controlled Terminology VersionSEND Terminology 2021-03-26
17123ALLTS1
SSPONSORSponsor OrganizationExample Sponsor Inc.
18123ALLTS1
SPREFIDSponsor's Study Reference ID
NOT APPLICABLE
19123ALLTS11TSTFNAMTest Facility NameExample Tox Lab Name
20123

ALL

TS11TSTFLOCTest Facility Location10 Somewhere Street, Montgomery, AL 10000
21123ALLTS11TFCNTRYTest Facility CountryUSA
24123ALLTS11STDIRStudy DirectorDr. R. Smith
28123ALLTS1
GLPFLGLP FlagY
29123MNvitTS1
ASTDAssay StandardOECD Test No. 487 
30123MNvitTS1
ASTDVAssay Standard Version2016-07-29
31123MNvitTS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
32123MNvitTS1
SSSTYPStudy Sub TypeIn Vitro Micronucleus
33123MNvitTS1
SPECIESSpeciesHomo Sapiens
34123MNvitTS1
??Test System?TK6 Lymphoblastoid Suspension Cells
35123NRUTS1
ASTDAssay StandardNIH Publication No. 07-4519
36123NRUTS1
ASTDVAssay Standard Version2006-11
37123NRUTS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
38123NRUTS1
SSSTYPStudy Sub TypeIn Vitro Neutral Red Uptake
39123NRUTS1
SPECIESSpeciesSalmonella enterica 

123NRUTS1
STRAINStrain/SubstrainSalmonella enterica enterica

40

123NRUTS1
??Test System??Normal Human Keratinocyte

123NRUTS1
REGIMESmoking RegimeTraditional combustible 

123NRUTS1





123NRUTS1
RUNPRTrun-port number?? (always same for whole assay?)

1-1



123NRUTS1
SMPLIDSample ID030001

123NRUTS1
SMKFRCSmoke FractionA

123NRUTS1
REPNUMReplicate Number1

123NRUTS1





Image RemovedImage Added

Expand
titletx.xpt (trial sets)
  • During CT definition/reviews will decide appropriate TXPARM and TXVAL;  For now, we just include good example values based on our experience
  • TXPARMCD/TXPARM = TSPARMCD/TSPARM
RowSTUDYIDASSAYIDDOMAINSETCD
SET (what sponsor calls it)
TXSEQTXPARMCDTXPARMTXVAL
1123NRUTX1-1-A
(plate-col-row in the 96-well plate)
CSC-10
(through SLS-200)
RNPRTRun-port number1-1

PLATENUM. (e.g., 1 or 2)
1
1-1-APLATENUM1  (or 2)




1-1-A
WELLNUM
CSC-10
WELLNUM (e.g., 1-A
(
through
12
10-H)
Number representing the location of the well in the 96-well plate1-A 




1-1-ACSC-10
INTRVNname of the intervention articleCigarette Smoke Condensate




1-1-ACSC-10
ITVTYPE
(CT e.g, Product, positive control, negative control)
type of intervention article
Product
PRODUCT




1-1-ACSC-10
ITVCONCintervention concentration10




1-1-ACSC-10
ITVCONCUintervention unitug/ml




1-1
-A
-BCSC-10
PLATENUMPlate number1  




1-1-B
123
CSC-10
MNvitTXA2METACTMetabolic Activation+S9123MNvitTXA2TRTDURTreatment DurationShort Term123MNvitTXA2PRDCONCConcentration of product1250123MNvitTXA2PRDCONCUConcentration Unitug/ml123MNvitTXA2ProductProduct Name123MNvitTXA2Smoking Regime123MNvitTXA2Smoke FractionA6METACTTRTDUR

WELLNUMNumber representing the location of the well in the 96-well plate2-A 




1-1-BCSC-10
INTRVNname of the intervention articleCigarette Smoke Condensate




1-1-BCSC-10
ITVTYPEtype of intervention articlePRODUCT




1-1-BCSC-10
ITVCONCintervention concentration10




1-1-BCSC-10
ITVCONCUintervention unitug/ml




...








1-10-HSLS-10
PLATENUMPlate number1  




1-10-HSLS-10
WELLNUMNumber representing the location of the well in the 96-well plate10-H




1-10-HSLS-10
INTRVNname of the intervention article
Cyclophosphamid A
sodium laurel sulfate




1-10-HSLS-10
ITVTYPEtype of intervention article
Positive controlITVCONCConcentration of i a 5
POSITIVE CONTROL




1-10-HSLS-10
ITVCONCintervention concentration200




1-10-HSLS-10
ITVCONCUintervention unit
A6ITVCONCUConcentration Unit
ug/ml
A6TCNTL123MNvitTX

B1

METACTMetabolic Activation-S9123MNvitTX

B1

TRTDRTRGTreatment Duration target4TRTDRTOLTreatment Duration Tolerance.25??123MNvitTXB1TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)H




...








2-10-HSLS-10
PLATENUMPlate number2




2-10-HSLS-10
WELLNUMNumber representing the location of the well in the 96-well plate2-A 




2-10-HSLS-10
INTRVNname of the intervention articlesodium laurel sulfate




2-10-HSLS-10
ITVTYPEtype of intervention articlePOSITIVE CONTROL




2-10-HSLS-10
ITVCONCintervention concentration200




2-10-HSLS-10
ITVCONCUintervention unitug/ml
123MNvitTX

B1

PRDCONCConcentration of product0123MNvitTX

B1

PRDCONCUConcentration Unitug/ml123MNvitTXB1ProductProduct Name123MNvitTXB1Smoking Regime123MNvitTXB1Smoke Fraction123MNvitTX

C1

METACTMetabolic Activation-S9123MNvitTX

C1

TRTDURTreatment Duration24??123MNvitTXC1TRTDURUTreatment Duration UnitH123MNvitTX

C1

PRDCONCConcentration of product0123MNvitTX

C1

PRDCONCUConcentration Unitug/ml123MNvitTX

C1

ProductProduct Name123MNvitTXC1Smoking Regime123MNvitTX

C1

Smoke Fraction
Expand
titlegt.xpt (similar to LB)
RowSTUDYIDASSAYIDDOMAINTXCDGTSEQGTTESTCDGTTESTGTCELLEV
(cells evaluated)
GTORRESGTORRESUGTSTRESCGTSTRESNGTSTRESUGTDTCGTNOMDYGTELTMGTTPTREF




1-1-A1RELABSRelative Absorbance Reading
100ug/ml100100ug/ml








2...















8AVGREL












































































































































































10123MNvitGTA12RCC
1540%00%2022-05-25


11123MNvitGTA13RPD
1540%00%2022-05-25


12123MNvitGTA14MNCELLSMicronucleated Cells326615Cells1515Cells2022-05-25


13123MNvitGTA15MNCELLSMicronucleated Cells219013Cells1313Cells2022-05-25


14123MNvitGTA16MNCELLSMicronucleated Cells275817Cells1717Cells2022-05-25


15123MNvitGTA17MNCELLSMicronucleated Cells271412Cells1212Cells2022-05-25


16123MNvitGTA18AVGRELAverage Relative MN Frequency
0.57%0.570.57%2022-05-25